CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
601607 Shanghai Pharmaceuticals Holding
- 17.96
- -0.02-0.11%
Market Closed Apr 30 15:00 CST
66.60BMarket Cap15.34P/E (TTM)
18.08High17.92Low63.66KlotVolume18.00Open17.98Pre Close114.44MTurnover0.23%Turnover Ratio14.63P/E (Static)3.71BShares23.2052wk High0.91P/B50.09BFloat Cap17.2852wk Low19.78Limit Up2.79BShs Float27.89Historical High16.18Limit Down0.89%Amplitude-2.54Historical Low0.49Dividend TTM17.98Avg Price34.94KlotAsk2.73%Div YieldTTM100Lot Size26.71KlotBid
Shanghai Pharmaceuticals Holding Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 0.87%70.76B | 5.75%275.25B | 6.14%209.63B | 5.14%139.41B | 5.93%70.15B | 12.21%260.3B | 13.11%197.51B | 18.70%132.59B | 16.39%66.23B | 7.49%231.98B |
| Operating revenue | 0.87%70.76B | 5.75%275.25B | 6.14%209.63B | 5.14%139.41B | 5.93%70.15B | 12.21%260.3B | 13.11%197.51B | 18.70%132.59B | 16.39%66.23B | 7.49%231.98B |
| Other operating revenue | ---- | -6.88%1.06B | ---- | -13.29%425.22M | ---- | 54.20%1.14B | ---- | 27.13%490.42M | ---- | -5.29%741.24M |
| Total operating cost | 1.14%68.67B | 5.80%267.68B | 6.30%203.43B | 5.21%134.89B | 6.03%67.89B | 12.49%253.01B | 13.27%191.38B | 19.12%128.21B | 16.29%64.03B | 7.28%224.91B |
| Operating cost | 2.22%63.51B | 6.84%244.62B | 7.44%186.45B | 6.67%123.25B | 7.87%62.12B | 13.63%228.97B | 14.22%173.55B | 19.50%115.53B | 16.19%57.59B | 7.59%201.49B |
| Operating tax surcharges | -2.64%203.04M | 5.39%777.88M | 8.50%594.97M | 5.97%399.68M | 8.20%208.54M | 3.05%738.11M | 1.71%548.36M | 0.73%377.17M | 5.29%192.74M | 7.51%716.27M |
| Operating expense | -16.11%2.76B | -8.55%12.71B | -9.46%9.48B | -15.10%6.57B | -15.86%3.29B | -2.64%13.9B | 1.29%10.47B | 13.81%7.73B | 18.05%3.91B | 7.22%14.28B |
| Administration expense | -4.81%1.32B | -0.38%5.69B | -1.22%4.14B | 3.86%2.87B | 0.90%1.39B | 14.43%5.71B | 11.62%4.19B | 19.00%2.76B | 15.70%1.38B | -2.95%4.99B |
| Financial expense | 0.08%374.72M | -0.33%1.48B | -0.45%1.15B | -8.70%705.94M | -10.46%374.43M | 13.14%1.49B | 15.71%1.15B | 19.16%773.22M | 16.64%418.18M | 5.45%1.31B |
| -Interest expense (Financial expense) | -5.85%444.08M | -1.50%1.86B | -5.10%1.39B | -4.64%917.77M | -4.13%471.67M | 11.59%1.88B | 18.90%1.46B | 14.94%962.46M | 20.64%491.99M | 11.27%1.69B |
| -Interest Income (Financial expense) | 38.73%-83.49M | -13.11%-522.39M | -1.84%-363.3M | -20.80%-256.78M | -25.24%-136.28M | -5.37%-461.83M | -5.04%-356.74M | 1.95%-212.57M | -36.35%-108.81M | -29.60%-438.3M |
| Research and development | -0.88%497.02M | 8.64%2.39B | 10.09%1.62B | 7.67%1.11B | -7.26%501.45M | 4.35%2.2B | 5.70%1.47B | 26.76%1.03B | 20.82%540.69M | 6.29%2.11B |
| Credit Impairment Loss | 5.07%-255.37M | 19.22%-226.16M | -45.77%-432.22M | 12.80%-293.26M | -300.73%-269.02M | 10.40%-279.96M | -17.46%-296.51M | -54.49%-336.32M | 4.75%-67.13M | -46,192.99%-312.46M |
| Asset Impairment Loss | 23.13%33.52M | -9.46%-614.37M | -290.94%-64.75M | -155.26%-36.53M | 126.50%27.22M | -69.33%-561.28M | 30.98%33.91M | 67.55%66.1M | -404.59%-102.74M | -136.02%-331.47M |
| Other net revenue | -67.15%50.51M | 48.57%566.08M | 10.75%473.4M | 79.30%307.92M | -48.37%153.76M | -80.37%381.01M | -78.23%427.45M | -90.01%171.73M | 87.03%297.8M | -4.06%1.94B |
| Fair value change income | -27.65%37.8M | -49.63%203.85M | -40.51%142.2M | -41.94%114.29M | -41.55%52.25M | 85.03%404.73M | 225.04%239.02M | 675.23%196.84M | 240.65%89.4M | 206.18%218.74M |
| Invest income | 3.18%171.74M | 658.44%380.43M | 509.78%343.49M | 223.81%246.36M | 7.27%166.44M | -112.78%-68.12M | -118.83%-83.82M | -164.35%-198.99M | -13.67%155.16M | -70.57%533.12M |
| -Including: Investment income associates | 6.17%215.83M | 303.55%521.91M | 398.03%447.83M | 658.88%365.61M | 0.79%203.28M | -75.45%129.33M | -83.05%89.92M | -117.33%-65.42M | 1.23%201.68M | -33.29%526.74M |
| Asset deal income | -100.82%-903.05K | 103.26%187.97M | 39.44%145.83M | 88.91%139.31M | 405.21%110.04M | -93.57%92.48M | -92.67%104.58M | -94.83%73.75M | 188.72%21.78M | 2,368.58%1.44B |
| Other revenue | -4.65%63.72M | -20.02%634.37M | -21.25%338.85M | -62.81%137.74M | -66.80%66.83M | 101.43%793.16M | 76.49%430.28M | 172.59%370.36M | 178.59%201.32M | -21.06%393.76M |
| Operating profit | -11.11%2.15B | 6.18%8.14B | 1.72%6.67B | 5.99%4.83B | -3.05%2.41B | -14.95%7.67B | -13.98%6.56B | -21.40%4.56B | 24.83%2.49B | 9.86%9.01B |
| Add:Non operating Income | 29.26%18.74M | 284.37%156.4M | 23.92%34.09M | -16.81%15.06M | 3.94%14.5M | 24.14%40.69M | 40.32%27.51M | 81.03%18.11M | 202.29%13.95M | -60.01%32.78M |
| Less:Non operating expense | -0.53%12.41M | -57.60%277.11M | -9.29%58.48M | -43.54%23.94M | -1.31%12.48M | 173.40%653.63M | -11.74%64.47M | -17.26%42.4M | -3.91%12.65M | 66.45%239.08M |
| Total profit | -10.92%2.15B | 13.69%8.02B | 1.92%6.64B | 6.36%4.82B | -3.02%2.42B | -19.91%7.05B | -13.86%6.52B | -21.26%4.53B | 25.44%2.49B | 8.16%8.81B |
| Less:Income tax cost | -7.00%512.52M | 13.89%2.15B | 3.57%1.62B | 9.66%1.22B | 2.28%551.13M | 3.93%1.89B | -1.16%1.57B | -6.45%1.12B | 18.63%538.85M | -2.83%1.82B |
| Net profit | -12.08%1.64B | 13.62%5.87B | 1.40%5.02B | 5.28%3.6B | -4.48%1.87B | -26.11%5.17B | -17.22%4.95B | -25.14%3.42B | 27.46%1.95B | 11.43%6.99B |
| Net profit from continuing operation | -12.08%1.64B | 13.62%5.87B | 1.40%5.02B | 5.28%3.6B | -4.48%1.87B | -26.11%5.17B | -17.22%4.95B | -25.14%3.42B | 27.46%1.95B | 11.43%6.99B |
| Less:Minority Profit | -5.00%307.12M | -5.80%1.32B | -16.24%969.12M | -18.80%655.45M | -25.75%323.29M | 1.72%1.4B | -1.14%1.16B | -7.07%807.18M | 54.77%435.4M | 16.41%1.37B |
| Net profit of parent company owners | -13.56%1.33B | 20.82%4.55B | 6.78%4.05B | 12.72%2.94B | 1.62%1.54B | -32.92%3.77B | -21.13%3.8B | -29.38%2.61B | 21.31%1.52B | 10.28%5.62B |
| Earning per share | ||||||||||
| Basic earning per share | -14.29%0.36 | 20.59%1.23 | 5.83%1.09 | 11.27%0.79 | 2.44%0.42 | -36.65%1.02 | -28.97%1.03 | -37.17%0.71 | -6.82%0.41 | -10.06%1.61 |
| Diluted earning per share | -14.29%0.36 | 20.59%1.23 | 5.83%1.09 | 11.27%0.79 | 2.44%0.42 | -36.65%1.02 | -28.97%1.03 | -37.17%0.71 | -6.82%0.41 | -10.06%1.61 |
| Other composite income | -842.99%-3.44M | 50.59%-62.62M | 84.45%-26.59M | 70.99%-35.64M | 101.48%463.24K | 44.05%-126.72M | 53.77%-170.97M | 26.23%-122.85M | 17.92%-31.35M | -359.02%-226.48M |
| Other composite income of parent company owners | -25.78%-6.18M | 69.39%-38.19M | 79.19%-34.85M | 74.46%-32.41M | 83.92%-4.91M | 45.02%-124.77M | 54.18%-167.44M | 21.83%-126.92M | 24.57%-30.56M | -287.52%-226.93M |
| Other composite income of minority owners | -49.08%2.74M | -1,150.05%-24.43M | 334.02%8.26M | -179.44%-3.23M | 774.36%5.38M | -535.08%-1.95M | 20.56%-3.53M | 197.68%4.07M | -134.54%-797.26K | 101.34%449.15K |
| Total composite income | -12.29%1.64B | 15.23%5.81B | 4.47%5B | 8.12%3.56B | -2.90%1.87B | -25.51%5.04B | -14.81%4.78B | -25.09%3.29B | 28.62%1.92B | 6.34%6.77B |
| Total composite income of parent company owners | -13.69%1.33B | 23.91%4.51B | 10.75%4.02B | 17.18%2.91B | 3.38%1.54B | -32.41%3.64B | -18.41%3.63B | -29.73%2.48B | 22.85%1.49B | 3.37%5.39B |
| Total composite income of minority owners | -5.72%309.86M | -7.42%1.29B | -15.27%977.38M | -19.60%652.22M | -24.37%328.67M | 1.55%1.4B | -1.07%1.15B | -6.15%811.25M | 53.23%434.6M | 19.85%1.38B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.